Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Using resting-state intrinsic network connectivity to identify suicide risk in mood disorders.

Stange JP, Jenkins LM, Pocius S, Kreutzer K, Bessette KL, DelDonno SR, Kling LR, Bhaumik R, Welsh RC, Keilp JG, Phan KL, Langenecker SA.

Psychol Med. 2019 Oct 10:1-11. doi: 10.1017/S0033291719002356. [Epub ahead of print]

PMID:
31597581
2.

Suicidal subtypes, stress responsivity and impulsive aggression.

Stanley B, Michel CA, Galfalvy HC, Keilp JG, Rizk MM, Richardson-Vejlgaard R, Oquendo MA, Mann JJ.

Psychiatry Res. 2019 Oct;280:112486. doi: 10.1016/j.psychres.2019.112486. Epub 2019 Jul 16.

PMID:
31376789
3.

Childhood maltreatment, neuropsychological function and suicidal behavior.

Zelazny J, Melhem N, Porta G, Biernesser C, Keilp JG, Mann JJ, Oquendo MA, Stanley B, Brent DA.

J Child Psychol Psychiatry. 2019 Oct;60(10):1085-1093. doi: 10.1111/jcpp.13096. Epub 2019 Jul 24.

PMID:
31342521
4.

Cortisol Stress Response and in Vivo PET Imaging of Human Brain Serotonin 1A Receptor Binding.

Steinberg LJ, Rubin-Falcone H, Galfalvy HC, Kaufman J, Miller JM, Sublette ME, Cooper TB, Min E, Keilp JG, Stanley BH, Oquendo MA, Ogden RT, Mann JJ.

Int J Neuropsychopharmacol. 2019 May 1;22(5):329-338. doi: 10.1093/ijnp/pyz009.

5.

Resting-state amplitude of low-frequency fluctuation is associated with suicidal ideation.

Lan MJ, Rizk MM, Pantazatos SP, Rubin-Falcone H, Miller JM, Sublette ME, Oquendo MA, Keilp JG, Mann JJ.

Depress Anxiety. 2019 May;36(5):433-441. doi: 10.1002/da.22888. Epub 2019 Mar 21.

PMID:
30900329
6.

Severity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals.

Melhem NM, Porta G, Oquendo MA, Zelazny J, Keilp JG, Iyengar S, Burke A, Birmaher B, Stanley B, Mann JJ, Brent DA.

JAMA Psychiatry. 2019 Jun 1;76(6):603-613. doi: 10.1001/jamapsychiatry.2018.4513.

PMID:
30810713
7.

Correspondence on Curran et al. (2018): 'Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects'.

Vadhan NP, Corcoran CM, Keilp JG, Haney M.

Psychol Med. 2019 May;49(7):1227-1228. doi: 10.1017/S0033291718004178. Epub 2019 Jan 29. No abstract available.

PMID:
30691542
8.

Resting regional brain activity correlates of verbal learning deficit in major depressive disorder.

Milak MS, Potter WA, Pantazatos SP, Keilp JG, Zanderigo F, Schain M, Sublette ME, Oquendo MA, Malone KM, Brandenburg H, Parsey RV, Mann JJ.

Psychiatry Res Neuroimaging. 2019 Jan 30;283:96-103. doi: 10.1016/j.pscychresns.2018.12.006. Epub 2018 Dec 8.

PMID:
30580237
9.

Gray matter volumetric study of major depression and suicidal behavior.

Rizk MM, Rubin-Falcone H, Lin X, Keilp JG, Miller JM, Milak MS, Sublette ME, Oquendo MA, Ogden RT, Abdelfadeel NA, Abdelhameed MA, Mann JJ.

Psychiatry Res Neuroimaging. 2019 Jan 30;283:16-23. doi: 10.1016/j.pscychresns.2018.11.007. Epub 2018 Nov 14.

PMID:
30469094
10.

Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder.

Keilp JG, Corbera K, Gorlyn M, Oquendo MA, Mann JJ, Fallon BA.

Arch Clin Neuropsychol. 2019 Jun 1;34(4):466-480. doi: 10.1093/arclin/acy083.

PMID:
30418507
11.

The impact of cognitive reserve on neurocognitive performance in Major Depressive Disorder.

Venezia RG, Gorlyn M, Burke AK, Oquendo MA, Mann JJ, Keilp JG.

Psychiatry Res. 2018 Dec;270:211-218. doi: 10.1016/j.psychres.2018.09.031. Epub 2018 Sep 15.

PMID:
30267985
12.

Neurocognitive performance predicts treatment outcome with cognitive behavioral therapy for major depressive disorder.

Metts AV, Keilp JG, Kishon R, Oquendo MA, Mann JJ, Miller JM.

Psychiatry Res. 2018 Nov;269:376-385. doi: 10.1016/j.psychres.2018.08.011. Epub 2018 Aug 13.

PMID:
30173044
13.

The lack of meaningful association between depression severity measures and neurocognitive performance.

Keilp JG, Madden SP, Gorlyn M, Burke AK, Oquendo MA, Mann JJ.

J Affect Disord. 2018 Dec 1;241:164-172. doi: 10.1016/j.jad.2018.08.034. Epub 2018 Aug 8.

PMID:
30121449
14.

Effects of anxiety on suicidal ideation: exploratory analysis of a paroxetine versus bupropion randomized trial.

Parris MS, Marver JE, Chaudhury SR, Ellis SP, Metts AV, Keilp JG, Burke AK, Oquendo MA, Mann JJ, Grunebaum MF.

Int Clin Psychopharmacol. 2018 Sep;33(5):249-254. doi: 10.1097/YIC.0000000000000225.

15.

Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison Groups.

Doshi S, Keilp JG, Strobino B, McElhiney M, Rabkin J, Fallon BA.

Psychosomatics. 2018 Sep - Oct;59(5):481-489. doi: 10.1016/j.psym.2018.02.004. Epub 2018 Mar 1.

16.

Pathways to Late-Life Suicidal Behavior: Cluster Analysis and Predictive Validation of Suicidal Behavior in a Sample of Older Adults With Major Depression.

Szanto K, Galfalvy H, Vanyukov PM, Keilp JG, Dombrovski AY.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 17m11611. doi: 10.4088/JCP.17m11611.

17.

Toward subtyping of suicidality: Brief suicidal ideation is associated with greater stress response.

Rizk MM, Galfalvy H, Singh T, Keilp JG, Sublette ME, Oquendo MA, Mann JJ, Stanley B.

J Affect Disord. 2018 Apr 1;230:87-92. doi: 10.1016/j.jad.2018.01.012.

18.

The Data as It Is, and the Nature of Neurocognitive Difficulties in Post-Treatment Lyme Disease.

Keilp JG, Fallon BA.

Arch Clin Neuropsychol. 2018 Dec 1;33(8):1083-1085. doi: 10.1093/arclin/acx121. No abstract available.

PMID:
29244055
19.

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.

Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ.

Am J Psychiatry. 2018 Apr 1;175(4):327-335. doi: 10.1176/appi.ajp.2017.17060647. Epub 2017 Dec 5.

20.

Suicidal ideation declines with improvement in the subjective symptoms of major depression.

Keilp JG, Ellis SP, Gorlyn M, Burke AK, Oquendo MA, Mann JJ, Grunebaum MF.

J Affect Disord. 2018 Feb;227:65-70. doi: 10.1016/j.jad.2017.09.018. Epub 2017 Sep 19.

PMID:
29053977
21.

Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Vadhan NP, Corcoran CM, Bedi G, Keilp JG, Haney M.

Psychiatry Res. 2017 Nov;257:372-374. doi: 10.1016/j.psychres.2017.07.070. Epub 2017 Aug 1.

22.

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial.

Grunebaum MF, Ellis SP, Keilp JG, Moitra VK, Cooper TB, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ.

Bipolar Disord. 2017 May;19(3):176-183. doi: 10.1111/bdi.12487. Epub 2017 Apr 28.

PMID:
28452409
23.

Development, Administration, and Structural Validity of a Brief, Computerized Neurocognitive Battery: Results From the Army Study to Assess Risk and Resilience in Servicemembers.

Moore TM, Gur RC, Thomas ML, Brown GG, Nock MK, Savitt AP, Keilp JG, Heeringa S, Ursano RJ, Stein MB; Army STARRS Collaborators * .

Assessment. 2019 Jan;26(1):125-143. doi: 10.1177/1073191116689820. Epub 2017 Jan 30.

24.

Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.

Mourik K, Decrescenzo P, Brucato G, Gill KE, Arndt L, Kimhy D, Keilp JG, Girgis RR.

Early Interv Psychiatry. 2017 Jun;11(3):250-254. doi: 10.1111/eip.12296. Epub 2015 Dec 10.

25.

Further evidence of low baseline cortisol levels in suicide attempters.

Keilp JG, Stanley BH, Beers SR, Melhem NM, Burke AK, Cooper TB, Oquendo MA, Brent DA, John Mann J.

J Affect Disord. 2016 Jan 15;190:187-192. doi: 10.1016/j.jad.2015.10.012. Epub 2015 Oct 23.

PMID:
26519639
26.

Blunted HPA Axis Activity in Suicide Attempters Compared to those at High Risk for Suicidal Behavior.

Melhem NM, Keilp JG, Porta G, Oquendo MA, Burke A, Stanley B, Cooper TB, Mann JJ, Brent DA.

Neuropsychopharmacology. 2016 May;41(6):1447-56. doi: 10.1038/npp.2015.309. Epub 2015 Oct 9.

27.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

28.

Lateralization for speech predicts therapeutic response to cognitive behavioral therapy for depression.

Kishon R, Abraham K, Alschuler DM, Keilp JG, Stewart JW, McGrath PJ, Bruder GE.

Psychiatry Res. 2015 Aug 30;228(3):606-11. doi: 10.1016/j.psychres.2015.04.054. Epub 2015 Jun 11.

29.

Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

Corcoran CM, Keilp JG, Kayser J, Klim C, Butler PD, Bruder GE, Gur RC, Javitt DC.

Psychol Med. 2015 Oct;45(14):2959-73. doi: 10.1017/S0033291715000902. Epub 2015 Jun 4.

30.

Social inference in individuals at clinical high risk for psychosis.

Gill KE, Cressman V, Poe SL, Steinfeld S, Ben-David S, Keilp JG, Moore H, Turkstra LS, Corcoran C.

Early Interv Psychiatry. 2016 Feb;10(1):77-80. doi: 10.1111/eip.12182. Epub 2014 Sep 9.

PMID:
25203733
31.

Neuropsychological deficits in past suicide attempters with varying levels of depression severity.

Keilp JG, Beers SR, Burke AK, Melhem NM, Oquendo MA, Brent DA, Mann JJ.

Psychol Med. 2014 Oct;44(14):2965-74. doi: 10.1017/S0033291714000786. Epub 2014 Apr 9.

32.

Neurocognitive predictors of antidepressant clinical response.

Bruder GE, Alvarenga JE, Alschuler D, Abraham K, Keilp JG, Hellerstein DJ, Stewart JW, McGrath PJ.

J Affect Disord. 2014 Sep;166:108-14. doi: 10.1016/j.jad.2014.04.057. Epub 2014 May 4.

33.

Intact alternation performance in high lethality suicide attempters.

Keilp JG, Wyatt G, Gorlyn M, Oquendo MA, Burke AK, John Mann J.

Psychiatry Res. 2014 Sep 30;219(1):129-36. doi: 10.1016/j.psychres.2014.04.050. Epub 2014 May 9.

34.

Ongoing discussion about the US clinical Lyme trials.

Fallon BA, Petkova E, Keilp JG, Britton CB.

Am J Med. 2014 Feb;127(2):e7. doi: 10.1016/j.amjmed.2013.09.005. No abstract available.

PMID:
24462018
35.

Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder.

Sublette ME, Galfalvy HC, Hibbeln JR, Keilp JG, Malone KM, Oquendo MA, Mann JJ.

Int J Neuropsychopharmacol. 2014 Mar;17(3):383-91. doi: 10.1017/S1461145713001399. Epub 2013 Dec 3.

36.

SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.

Grunebaum MF, Keilp JG, Ellis SP, Sudol K, Bauer N, Burke AK, Oquendo MA, Mann JJ.

J Clin Psychiatry. 2013 Sep;74(9):872-9. doi: 10.4088/JCP.12m08000.

37.

Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy.

Chandra AM, Keilp JG, Fallon BA.

Psychosomatics. 2013 Nov-Dec;54(6):552-9. doi: 10.1016/j.psym.2013.04.003. Epub 2013 Jul 9.

38.

Iowa gambling task performance in currently depressed suicide attempters.

Gorlyn M, Keilp JG, Oquendo MA, Burke AK, John Mann J.

Psychiatry Res. 2013 May 30;207(3):150-7. doi: 10.1016/j.psychres.2013.01.030. Epub 2013 Mar 13.

PMID:
23489594
39.

A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome.

Fallon BA, Petkova E, Keilp JG, Britton CB.

Open Neurol J. 2012;6:79-87. doi: 10.2174/1874205X01206010079. Epub 2012 Oct 5.

40.

Neural responses to incongruency in a blocked-trial Stroop fMRI task in major depressive disorder.

Kikuchi T, Miller JM, Schneck N, Oquendo MA, Mann JJ, Parsey RV, Keilp JG.

J Affect Disord. 2012 Dec 20;143(1-3):241-7. doi: 10.1016/j.jad.2012.05.016. Epub 2012 Sep 17.

41.

Neuropsychological function and suicidal behavior: attention control, memory and executive dysfunction in suicide attempt.

Keilp JG, Gorlyn M, Russell M, Oquendo MA, Burke AK, Harkavy-Friedman J, Mann JJ.

Psychol Med. 2013 Mar;43(3):539-51. doi: 10.1017/S0033291712001419. Epub 2012 Jul 10.

42.

Suicidal ideation and the subjective aspects of depression.

Keilp JG, Grunebaum MF, Gorlyn M, LeBlanc S, Burke AK, Galfalvy H, Oquendo MA, Mann JJ.

J Affect Disord. 2012 Sep;140(1):75-81. doi: 10.1016/j.jad.2012.01.045. Epub 2012 Mar 9.

43.

Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.

Culang-Reinlieb ME, Sneed JR, Keilp JG, Roose SP.

Int J Geriatr Psychiatry. 2012 Aug;27(8):777-84. doi: 10.1002/gps.2783. Epub 2011 Sep 15.

44.

Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression.

Sneed JR, Culang ME, Keilp JG, Rutherford BR, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2010 Feb;18(2):128-35. doi: 10.1097/JGP.0b013e3181c796d2.

45.

Change in cognitive functioning following acute antidepressant treatment in late-life depression.

Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP, Roose SP.

Am J Geriatr Psychiatry. 2009 Oct;17(10):881-8.

46.

Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy.

Fallon BA, Lipkin RB, Corbera KM, Yu S, Nobler MS, Keilp JG, Petkova E, Lisanby SH, Moeller JR, Slavov I, Van Heertum R, Mensh BD, Sackeim HA.

Arch Gen Psychiatry. 2009 May;66(5):554-63. doi: 10.1001/archgenpsychiatry.2009.29.

PMID:
19414715
47.

Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.

Gorlyn M, Keilp JG, Grunebaum MF, Taylor BP, Oquendo MA, Bruder GE, Stewart JW, Zalsman G, Mann JJ.

J Neural Transm (Vienna). 2008 Aug;115(8):1213-9. doi: 10.1007/s00702-008-0084-x. Epub 2008 Jul 16.

48.

Future suicide attempt and responses to serotonergic challenge.

Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ.

Neuropsychopharmacology. 2010 Apr;35(5):1063-72. doi: 10.1038/npp.2008.28. Epub 2008 Mar 19.

49.

Attention deficit in depressed suicide attempters.

Keilp JG, Gorlyn M, Oquendo MA, Burke AK, Mann JJ.

Psychiatry Res. 2008 May 30;159(1-2):7-17. doi: 10.1016/j.psychres.2007.08.020. Epub 2008 Mar 10.

50.

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.

Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA.

Neurology. 2008 Mar 25;70(13):992-1003. Epub 2007 Oct 10.

PMID:
17928580

Supplemental Content

Loading ...
Support Center